Nothing Special   »   [go: up one dir, main page]

Brown et al., 1970 - Google Patents

The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits

Brown et al., 1970

View PDF
Document ID
16726604600568613019
Author
Brown D
Lachmann P
Dacie J
Publication year
Publication venue
Clinical and Experimental Immunology

External Links

Snippet

Two series of experiments were performed on rabbits to investigate the role of fixed C3 in the non-lytic destruction of red cells. In the first series, intravenous injection of a potentially lytic IgM cold antibody (anti-I) into C6-deficient rabbits caused a severe thrombocytopenia …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Brown et al. The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits
Jandl et al. The destruction of red cells by antibodies in man. III. Quantitative factors influencing the patterns of hemolysis in vivo
Wisløff et al. Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B-and T-lymphocytes
Meri et al. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Landy et al. Humoral and cellular aspects of the immune response to the somatic antigen of Salmonella enteritidis
Schorer et al. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells
Fauci et al. Activation of human B lymphocytes: XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total-immunoglobulin producing plaque-forming cells in peripheral blood
Boldt et al. Interaction of plant lectins with purified human lymphocyte populations: Binding characteristics and kinetics of proliferation
Thomson et al. Clearance of Rh D-positive red cells with monoclonal anti-D
Evans et al. Chronic hemolytic anemia due to cold agglutinins: II. The role of C′ in red cell destruction
Lenny et al. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers
Thomson et al. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
Chiller et al. Restoration of immunocompetency in tolerant lymphoid cell populations by cellular supplementation
Chisari Regulation of human lymphocyte function by a soluble extract from normal human liver
Huber et al. Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies
Pressman et al. The Zone of Localization of Antibodies: XII. Immunological Specificities and Cross Reactions in the Vascular Beds of Liver, Kidney and Lung
Mizutani et al. T‐cell abnormalities in patients with idiopathic thrombocytopenic purpura: The presence of OKT4+ 8+ cells
Pressman et al. The zone of localization of antibodies. XIII. The in vivo localization of anti-liver-blood-vessel antibodies in the rat
Harbour et al. Splenic lymphocyte production of an endorphin during endotoxic shock
El Sheikh et al. T lymphocytemediated cytotoxicity in HBsAg-positive liver disease
Sancho et al. Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.
Von dem Borne et al. IgG4 autoantibodies against erythrocytes, without increased haemolysis: a case report
THURLOW et al. A MONOCLONAL ANTI-PAN-T-CELL ANTIBODY IN VITRO AND IN VIVO STUDIES
Loegering et al. Depressing hepatic macrophage complement receptor function causes increased susceptibility to endotoxemia and infection
Vanderberg et al. Role of the carbohydrate domains of glycophorins as erythrocyte receptors for invasion by Plasmodium falciparum merozoites